A NUMBER of preparations of monoamine oxidase (monoamine: O2 oxidoreductase (deaminating) E.C.184.108.40.206.) (MAO) have been shown to contain multiple forms of the enzyme which differ in their electrophoretic mobilities1, 2, inhibitor sensitivities3–5, thermal stabilities6 and, in some cases, immunological properties7–8. Little is known about the nature of these multiple forms although it has been suggested that they might be protein conformers9. The possibility that they might arise from the binding of different amounts or types of lipid material to a single enzyme species is, however, supported by the observation that the electrophoretically separable forms of rat liver MAO contain widely different amounts of phospholipid5, 10. In addition we have recently shown that treatment of a preparation of rat liver monoamine oxidase with the chaotropic agent sodium perchiorate seemed to render the enzyme homogeneous by a number of criteria without any significant loss of activity10. This treatment was shown to be accompanied by the release of lipid material from the enzyme preparation and, since chaotropic agents are known to weaken hydrophobic bonds between protein and lipid11, these results gave further support to the view that the multiple forms are caused by the association of lipid membrane material with a single enzyme.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Experimental & Molecular Medicine Open Access 09 July 2021
Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Youdim, M. B. H., Collins, G. G. S., and Sandler, M., Fed. Eur. Biochem. Soc. Symp., 18, 281 (1970).
Diaz Borges, J. M., and D'lorio, A., Adv. Biochem. Psychopharmac., 5, 79 (1972).
Hall, D. W. R., Logan, B. W., and Parsons, G. H., Biochem. Pharmac., 18, 1447 (1969).
Squires, R. F., Adv. Biochem. Psychopharmac., 5, 355 (1972).
Tipton, K. F., Adv. Biochem. Psychopharmac., 5, 11 (1972).
Oswald, E. O., and Strittmatter, C. F., Proc Soc. exp. Biol. Med., 114, 668 (1963).
Hartman, B. K., Biol. Psych., 4, 147 (1972).
McCauley, R., and Racker, E., Molec. Cell. Biochem., 1, 73 (1973).
Collins, G. G. S., Sandler, M., Williams, E. D., and Youdim, M. B. H., Nature, 225, 817 (1970).
Houslay, M. D., and Tipton, K. F., Biochem. J., 135, 173 (1973).
Hanstein, W. G., Davis, K. A., and Hatefi, Y., Archs. Biochem. Biophys., 147, 534 (1971).
Shih, J.-H. C., and Eiduson, S., Nature, 224, 1309 (1969).
Youdim, M. B. H., Collins, G. G. S., Sandler, M., Bevan Jones, A. B., Pare, C. M., and Nicholson, W. J., Nature, 236, 225 (1972).
Eiduson, S., Adv. Biochem. Psychopharmac., 5, 271 (1972).
Nagatsu, T., Nakano, G., Mizutani, K., and Harada, M., Adv. Biochem. Psychopharmac., 5, 25 (1972).
Oreland, L., Archs. Biochem. Biophys., 146, 410 (1971).
Gomes, B., Igaue, I., Kloepfer, H. G., and Yasunobu, K. T., Archs. Biochem. Biophys., 132, 16 (1969).
Jarrott, B., J. Neurochem., 18, 7 (1971).
Kroon, M. C., and Veldstra, H., FEBS Lett., 24, 173 (1972).
Neff, N. H., in Frontiers in Catecholamine Research (edit, by Usdin, E., and Snyder, S. H.) (Pergamon Press, London and New York) (in the press).
Youdim, M. B. H., Trans. Biochem. Soc. (in the press).
About this article
Cite this article
TIPTON, K., HOUSLAY, M. & GARRETT, N. AUotopic Properties of Human Brain Monoamine Oxidase. Nature New Biology 246, 213–214 (1973). https://doi.org/10.1038/newbio246213a0
This article is cited by
Experimental & Molecular Medicine (2021)
In vivo labelling and axonal transport of monoamine oxidase in the rat basal ganglia using radioactive pargyline
Journal of Neural Transmission (1986)
Intra- and extraneuronal monoamineoxidase-A and -B activities after central axotomy (hemisection) on rats
Journal of Neural Transmission (1985)
Naunyn-Schmiedeberg's Archives of Pharmacology (1983)
Veterinary Research Communications (1983)